Cutting edge: Activation of virus-specific CD4 T cells throughout γ-herpesvirus latency

Journal of Immunology

Volumn 187, Issue 12, 2011, Pages 6180-6184

  Freeman, Michael L ^a   Burkum, Claire E ^a   Lanzer, Kathleen G ^a   Jensen, Meghan K ^a   Ahmed, Mushtaq ^b   Yager, Eric J ^c   Flanõ, Emilio ^d   Winslow, Gary M ^e   Woodland, David L ^a   Blackman, Marcia A ^a  

^a TRUDEAU INSTITUTE   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c ALBANY COLLEGE OF PHARMACY AND HEALTH SCIENCES   (United States)

^d NATIONWIDE CHILDREN S HOSPITAL   (United States)

^e WADSWORTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; MICROSOMAL AMINOPEPTIDASE; T LYMPHOCYTE RECEPTOR; VIRUS GLYCOPROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; DENDRITIC CELL; GAMMAHERPESVIRINAE; LATENT VIRUS INFECTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; TRANSGENIC MOUSE; VIRUS LATENCY;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; EPITOPES, T-LYMPHOCYTE; HERPESVIRIDAE INFECTIONS; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; RECEPTORS, ANTIGEN, T-CELL; RHADINOVIRUS; VIRUS ACTIVATION; VIRUS LATENCY;

EID: 83755184225     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1102745     Document Type: Article

References (24)

1. Klenerman, P., and A. Hill. 2005. T cells and viral persistence: lessons from diverse infections. Nat. Immunol. 6: 873-879. (Pubitemid 43090441)
2. Robey, R. C., D. Lagos, F. Gratrix, S. Henderson, N. C. Matthews, R. J. Vart, M. Bower, C. Boshoff, and F. M. Gotch. 2009. The CD8 and CD4 T-cell response against Kaposi's sarcoma-associated herpesvirus is skewed towards early and late lytic antigens. PLoS One 4: e5890.
3. Münz, C., K. L. Bickham, M. Subklewe, M. L. Tsang, A. Chahroudi, M. G. Kurilla, D. Zhang, M. O'Donnell, and R.M. Steinman. 2000. Human CD4(+) T lymphocytes consistently respond to the latent Epstein-Barr virus nuclear antigen EBNA1. J. Exp. Med. 191: 1649-1660. (Pubitemid 30331564)
4. Münz, C., and A. Moormann. 2008. Immune escape by Epstein-Barr virus associated malignancies. Semin. Cancer Biol. 18: 381-387.
5. da Silva, S. R., and D. E. de Oliveira. 2011. HIV, EBV and KSHV: viral cooperation in the pathogenesis of human malignancies. Cancer Lett. 305: 175-185.
6. Taylor, G. S., T. A. Haigh, N. H. Gudgeon, R. J. Phelps, S. P. Lee, N. M. Steven, and A. B. Rickinson. 2004. Dual stimulation of Epstein-Barr virus (EBV)-specific CD4+- and CD8+-T-cell responses by a chimeric antigen construct: potential therapeutic vaccine for EBV-positive nasopharyngeal carcinoma. J. Virol. 78: 768-778. (Pubitemid 38067599)
7. Merlo, A., R. Turrini, S. Bobisse, R. Zamarchi, R. Alaggio, R. Dolcetti, J. Mautner, P. Zanovello, A. Amadori, and A. Rosato. 2010. Virus-specific cytotoxic CD4+ T cells for the treatment of EBV-related tumors. J. Immunol. 184: 5895-5902.
8. Virgin, H. W., IV, P. Latreille, P. Wamsley, K. Hallsworth, K. E. Weck, A. J. Dal Canto, and S. H. Speck. 1997. Complete sequence and genomic analysis of murine gammaherpesvirus 68. J. Virol. 71: 5894-5904. (Pubitemid 27304926)
9. Liu, L., E. J. Usherwood, M. A. Blackman, and D. L. Woodland. 1999. T-cell vaccination alters the course of murine herpesvirus 68 infection and the establishment of viral latency in mice. J. Virol. 73: 9849-9857.
10. Flaño, E., D. L. Woodland, M. A. Blackman, and P. C. Doherty. 2001. Analysis of virus-specific CD4(+) T cells during long-term gammaherpesvirus infection. J. Virol. 75: 7744-7748. (Pubitemid 32738035)
11. Stewart, J. P., N. J. Janjua, S. D. Pepper, G. Bennion, M. Mackett, T. Allen, A. A. Nash, and J. R. Arrand. 1996. Identification and characterization of murine gammaherpesvirus 68 gp150: a virion membrane glycoprotein. J. Virol. 70: 3528-3535. (Pubitemid 26157332)
12. McSorley, S. J., S. Asch, M. Costalonga, R. L. Reinhardt, and M. K. Jenkins. 2002. Tracking Salmonella-specific CD4 T cells in vivo reveals a local mucosal response to a disseminated infection. Immunity 16: 365-377. (Pubitemid 34260915)
13. Reiley, W. W., M. D. Calayag, S. T. Wittmer, J. L. Huntington, J. E. Pearl, J. J. Fountain, C. A. Martino, A. D. Roberts, A. M. Cooper, G. M. Winslow, and D. L. Woodland. 2008. ESAT-6-specific CD4 T cell responses to aerosol Mycobacterium tuberculosis infection are initiated in the mediastinal lymph nodes. Proc. Natl. Acad. Sci. USA 105: 10961-10966.
14. Zhumabekov, T., P. Corbella, M. Tolaini, and D. Kioussis. 1995. Improved version of a human CD2 minigene based vector for T cell-specific expression in transgenic mice. J. Immunol. Methods 185: 133-140.
15. Cush, S. S., and E. Flaño. 2011. KLRG1+NKG2A+ CD8 T cells mediate protection and participate in memory responses during γ-herpesvirus infection. J. Immunol. 186: 4051-4058.
16. Obar, J. J., S. G. Crist, E. K. Leung, and E. J. Usherwood. 2004. IL-15-independent proliferative renewal of memory CD8+ T cells in latent gammaherpesvirus infection. J. Immunol. 173: 2705-2714. (Pubitemid 39063132)
17. Lin, E., C. C. Kemball, A. Hadley, J. J. Wilson, A. R. Hofstetter, C. D. Pack, and A. E. Lukacher. 2010. Heterogeneity among viral antigen-specific CD4+ T cells and their de novo recruitment during persistent polyomavirus infection. J. Immunol. 185: 1692-1700.
18. Martinez-Guzman, D., T. Rickabaugh, T. T. Wu, H. Brown, S. Cole, M. J. Song, L. Tong, and R. Sun. 2003. Transcription program of murine gammaherpesvirus 68. J. Virol. 77: 10488-10503. (Pubitemid 37129693)
19. Snyder, C. M., K. S. Cho, E. L. Bonnett, S. van Dommelen, G. R. Shellam, and A. B. Hill. 2008. Memory inflation during chronic viral infection is maintained by continuous production of short-lived, functional T cells. Immunity 29: 650-659.
20. Vezys, V., D. Masopust, C. C. Kemball, D. L. Barber, L. A. O'Mara, C. P. Larsen, T. C. Pearson, R. Ahmed, and A. E. Lukacher. 2006. Continuous recruitment of naive T cells contributes to heterogeneity of antiviral CD8 T cells during persistent infection. J. Exp. Med. 203: 2263-2269. (Pubitemid 44498361)
21. Kupresanin, F., J. Chow, A. Mount, C. M. Smith, P. G. Stevenson, and G. T. Belz. 2007. Dendritic cells present lytic antigens and maintain function throughout persistent gamma-herpesvirus infection. J. Immunol. 179: 7506-7513.
22. Cush, S. S., K. M. Anderson, D. H. Ravneberg, J. L. Weslow-Schmidt, and E. Flaño. 2007. Memory generation and maintenance of CD8+ T cell function during viral persistence. J. Immunol. 179: 141-153. (Pubitemid 46986528)
23. Flaño, E., S. M. Husain, J. T. Sample, D. L. Woodland, and M. A. Blackman. 2000. Latent murine gamma-herpesvirus infection is established in activated B cells, dendritic cells, and macrophages. J. Immunol. 165: 1074-1081. (Pubitemid 30484779)
24. Nikiforow, S., K. Bottomly, and G. Miller. 2001. CD4+ T-cell effectors inhibit Epstein-Barr virus-induced B-cell proliferation. J. Virol. 75: 3740-3752. (Pubitemid 32246383)